Tourangeau Greg 4
4 · Fulcrum Therapeutics, Inc. · Filed May 10, 2022
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Common Stock
2022-05-06+3,250→ 16,202 total - Award
Stock Option (right to buy)
2022-05-06+6,500→ 6,500 totalExercise: $8.63Exp: 2032-05-05→ Common Stock (6,500 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.
- [F2]This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date.